Christopher W. Crank

1.8k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Christopher W. Crank is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Christopher W. Crank has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 11 papers in Clinical Biochemistry. Recurrent topics in Christopher W. Crank's work include Bacterial Identification and Susceptibility Testing (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Infective Endocarditis Diagnosis and Management (7 papers). Christopher W. Crank is often cited by papers focused on Bacterial Identification and Susceptibility Testing (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Infective Endocarditis Diagnosis and Management (7 papers). Christopher W. Crank collaborates with scholars based in United States, Israel and Brazil. Christopher W. Crank's co-authors include John Segreti, Gourang Patel, Marc H. Scheetz, John Segreti, Michael J. Rybak, Ravina Kullar, Sara E. Cosgrove, Susan L. Davis, George Sakoulas and Donald P. Levine and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

Christopher W. Crank

24 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management

2015 385 citations Christopher W. Crank et al. Infection and Drug Resistance profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher W. Crank United States	19	842	481	462	218	195	25	1.4k
Levita Hidayat United States	11	737 0.9×	575 1.2×	245 0.5×	190 0.9×	302 1.5×	18	1.2k
Trevor Van Schooneveld United States	15	623 0.7×	372 0.8×	552 1.2×	143 0.7×	96 0.5×	89	1.3k
Alan H. Mutnick United States	17	385 0.5×	286 0.6×	270 0.6×	133 0.6×	212 1.1×	41	1.1k
Christopher J. Graber United States	21	1.2k 1.4×	613 1.3×	417 0.9×	352 1.6×	193 1.0×	66	2.0k
Michelle T. Hecker United States	14	720 0.9×	334 0.7×	528 1.1×	113 0.5×	143 0.7×	37	1.7k
Aisling R. Caffrey United States	21	530 0.6×	508 1.1×	610 1.3×	182 0.8×	326 1.7×	84	1.6k
Nadia Z. Haque United States	16	983 1.2×	597 1.2×	297 0.6×	392 1.8×	215 1.1×	32	1.3k
Belinda Ostrowsky United States	19	916 1.1×	383 0.8×	592 1.3×	174 0.8×	131 0.7×	54	1.5k
Sarah K. Parker United States	20	429 0.5×	401 0.8×	518 1.1×	285 1.3×	177 0.9×	84	1.6k
Carole Brennen United States	16	592 0.7×	335 0.7×	627 1.4×	106 0.5×	118 0.6×	21	1.4k

Countries citing papers authored by Christopher W. Crank

Since Specialization

Citations

This map shows the geographic impact of Christopher W. Crank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Crank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Crank more than expected).

Fields of papers citing papers by Christopher W. Crank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Crank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Crank. The network helps show where Christopher W. Crank may publish in the future.

Co-authorship network of co-authors of Christopher W. Crank

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher W. Crank. A scholar is included among the top collaborators of Christopher W. Crank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher W. Crank. Christopher W. Crank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rao, Sonia N., Nathaniel J. Rhodes, Benjamin J. Lee, et al.. (2015). Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 59(9). 5232–5238. 59 indexed citations

Crank, Christopher W., et al.. (2015). Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection and Drug Resistance. 8. 217–217. 385 indexed citations breakdown →

Crank, Christopher W., et al.. (2015). Evaluation of the relationship between opioid exposure in extremely low birth weight infants in the neonatal intensive care unit and neurodevelopmental outcome at 2years. Early Human Development. 92. 29–32. 46 indexed citations

Kullar, Ravina, Anthony M. Casapao, Susan L. Davis, et al.. (2013). A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. Journal of Antimicrobial Chemotherapy. 68(12). 2921–2926. 80 indexed citations

Nicolau, David P., Yehuda Carmeli, Christopher W. Crank, et al.. (2011). Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. International Journal of Antimicrobial Agents. 39(1). 11–15. 52 indexed citations

Kullar, Ravina, Susan L. Davis, Donald P. Levine, et al.. (2011). High‐Dose Daptomycin for Treatment of Complicated Gram‐Positive Infections: A Large, Multicenter, Retrospective Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(6). 527–536. 110 indexed citations

Beckett, Robert D., et al.. (2011). Effectiveness and Feasibility of Pharmacist-Led Admission Medication Reconciliation for Geriatric Patients. Journal of Pharmacy Practice. 25(2). 136–141. 43 indexed citations

Patel, Gourang, Christopher W. Crank, Omar Lateef, et al.. (2010). Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clinical Therapeutics. 32(7). 1285–1293. 23 indexed citations

Huhn, Gregory, Sheila Badri, Frank Tverdek, et al.. (2010). Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution. AIDS Research and Therapy. 7(1). 44–44. 16 indexed citations

10.

Patel, Gourang, Christopher W. Crank, & Jerrold B. Leikin. (2010). An Evaluation of Hepatotoxicity and Nephrotoxicity of Liposomal Amphotericin B (L-AMB). Journal of Medical Toxicology. 7(1). 12–15. 38 indexed citations

11.

Crank, Christopher W., et al.. (2010). Antifungal Distribution Into Cerebrospinal Fluid, Vitreous Humor, Bone, and Other Difficult Sites. Current Fungal Infection Reports. 4(2). 111–119. 11 indexed citations

12.

Crank, Christopher W., Marc H. Scheetz, Warren E. Rose, et al.. (2010). Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clinical Therapeutics. 32(10). 1713–1719. 57 indexed citations

13.

Patel, Gourang, David Simón, Marc H. Scheetz, et al.. (2009). The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock. American Journal of Therapeutics. 16(6). 508–511. 73 indexed citations

14.

Crank, Christopher W.. (2008). Comparison of Daptomycin (D) vs. Linezolid (L) for Vancomycin-Resistant Enterococcal Bacteremia (VRE). 46th Annual Meeting. 1 indexed citations

15.

Tverdek, Frank, Christopher W. Crank, & John Segreti. (2008). Antibiotic Therapy of Methicillin-Resistant Staphylococcus Aureus in Critical Care. Critical Care Clinics. 24(2). 249–260. 26 indexed citations

16.

Burke, John M., William A. Miller, Anne P. Spencer, et al.. (2008). Clinical Pharmacist Competencies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(6). 806–815. 126 indexed citations

17.

Gettig, Jacob P., et al.. (2007). Faropenem Medoxomil. Annals of Pharmacotherapy. 42(1). 80–90. 19 indexed citations

18.

Segreti, John, et al.. (2006). Daptomycin for the Treatment of Gram‐Positive Bacteremia and Infective Endocarditis: A Retrospective Case Series of 31 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(3). 347–352. 68 indexed citations

19.

Crank, Christopher W.. (2006). Effect of Ertapenem Utilization on Pseudomonas aeruginosa Susceptibility to Imipenem. 3 indexed citations

20.

Crank, Christopher W., et al.. (2005). Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections. Current Medical Research and Opinion. 21(12). 1923–1926. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact